These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22272897)

  • 21. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension.
    LaFleur J; Nelson RE; Sauer BC; Nebeker JR
    Heart; 2011 Nov; 97(22):1862-9. PubMed ID: 21586421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target blood pressure attainment in diabetic hypertensive patients: need for more diuretics?
    Sweileh WM
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):434-8. PubMed ID: 19640349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR; Zappe D; Orloski LA; Sowers JR
    J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of blood pressure control amongst hypertensive patients in Northwest Ethiopia.
    Teshome DF; Demssie AF; Zeleke BM
    PLoS One; 2018; 13(5):e0196535. PubMed ID: 29718964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Achieving Goal Blood Pressure.
    Laurent S
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S5-9. PubMed ID: 26002423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
    Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
    Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
    Kalaitzidis RG; Panagiotopoulou T; Stagikas D; Pappas K; Balafa O; Elisaf MS
    Curr Vasc Pharmacol; 2020; 18(4):410-417. PubMed ID: 30987567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined therapy in the treatment of hypertension.
    Escobar C; Barrios V
    Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Can we reduce the cardiovascular risk in hypertensive patients?].
    Plouin PF
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():7-8; discussion 29-30. PubMed ID: 9805562
    [No Abstract]   [Full Text] [Related]  

  • 31. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.
    Ahola TL; Kantola IM; Mäki J; Reunanen A; Jula AM
    Eur J Prev Cardiol; 2012 Aug; 19(4):712-22. PubMed ID: 21609976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures.
    Vigen R; Shetterly S; Magid DJ; O'Connor PJ; Margolis KL; Schmittdiel J; Ho PM
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):276-82. PubMed ID: 22576846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials.
    Heimark S; Mariampillai JE; Narkiewicz K; Nilsson PM; Kjeldsen SE
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):151-158. PubMed ID: 29663195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study.
    Matsumura K; Arima H; Tominaga M; Ohtsubo T; Sasaguri T; Fujii K; Fukuhara M; Uezono K; Morinaga Y; Ohta Y; Otonari T; Kawasaki J; Kato I; Tsuchihashi T;
    QJM; 2013 Oct; 106(10):909-14. PubMed ID: 23696676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database.
    Parati G; Dolan E; Ley L; Schumacher H
    J Hypertens; 2014 Jun; 32(6):1326-33. PubMed ID: 24759124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication adherence and resistant hypertension.
    Hyman DJ; Pavlik V
    J Hum Hypertens; 2015 Apr; 29(4):213-8. PubMed ID: 25209307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming barriers to effective blood pressure control in patients with hypertension.
    Düsing R
    Curr Med Res Opin; 2006 Aug; 22(8):1545-53. PubMed ID: 16870079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.